MONTREAL, Sept. 24, 2012 /CNW Telbec/ - Ranaz Corporation ("Ranaz") (TSXV: RNZ), a company specializing in the manufacturing and marketing of protein and dietary supplements, reports the nomination of Mr. André Brosseau as Chairman of the board.
Mr. Brosseau is CEO and COO of Avenue Capital Partners Inc., an exempt market dealer founded in 2010 with offices in Montreal and New York. He is also a Director of Midas Medici Inc., a holding company specializing in acquiring and merging IT related companies with operations in New York, North Carolina, Europe and Brazil. He's on the Board of CIMCORP, wholly owned by Midas Medici, an IT company based in Sao Paulo Brazil. Mr. Brosseau is Chairman of Vantex Resources Ltd, a public mining company. He also serves as the Co-Chair of The Company Theatre, a not-for-profit organization located in Toronto and member of the steering committee of Notman House. Mr. Brosseau holds a Bachelor's Degree (BA) in Science (Political and Economics) and a Master's Degree in Science (Political Science) from the Université de Montréal.
Mr. Brosseau was President of Blackmont Capital in Toronto until June 2009 and Chairman Quebec Capital Markets until May 2010. For 12 years Mr. Brosseau was with CIBC in different capacities mostly based in Toronto, most recently as Managing Director, Head of Cash Equities and Co-Head of Global Cash Equities at CIBC World Markets where he was involved in some of the most important capital market transactions in Canada.
"We are very excited that André Brosseau has chosen to join Ranaz. His expertise in investment banking will be a valuable asset for Ranaz shareholders," said Mr. Bourassa-Marineau, CEO of Ranaz.
About Ranaz Corporation
Ranaz is a corporation specializing in the manufacture and sale of protein and dietary supplements. Its mission is to design, develop and market nutritional, protein and dietary supplements under its own corporate brands and concepts, such as Protidiet and ProtiLife, as well as under private labels.
Full information, including the management discussion and analysis and the financial statements thereto, is available on SEDAR, at www.sedar.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the accuracy of this release.
SOURCE: Ranaz Corporation
For further information:
President and CEO
(450) 491-7106, local 217